[1]
Radhakrishnan K, Dinesh NS, Pradeep KS, Sankara SP. Profile of antiepileptic pharmacotherapy in a tertiary referral centre in South India: A pharmacoepidemiologic and pharmacoeconomic study. Epilepsia 1999; 40: 179-85.
[2]
Perucca E, Meador KJ. Adverse effects of antiepileptic drugs. Acta Neurol Scand 2005; 112(181): 30-5.
[3]
Clarkson A, Choonara I. Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002; 87: 462-6.
[4]
Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006; 118: 555-62.
[5]
Anderson M, Choonara I. A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period. Arch Dis Child 2010; 95: 731-8.
[6]
Bansal D, Azad C, Kaur M, Rudroju N, Vepa P, Guglani V. Adverse effects of antiepileptic drugs in North Indian pediatric outpatients. Clin Neuropharmacol 2013; 36: 107-13.
[7]
Morita DA, Glauser TA, Modi AC. Development and validation of the pediatric epilepsy side effects questionnaire. Neurology 2012; 79: 1252-8.
[8]
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-4.
[9]
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992; 49: 2229-32.
[10]
Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992; 27: 538.
[11]
Cloyd JC, Remmel RP. Antiepileptic drug pharmacokinetics and
interactions: Impact on treatment of epilepsy. Pharmacotherapy 2000; 20 Pt 2(8): 139S-51S.
[12]
Foletti GB. Clinical utilization of new anti-epileptic agents. Rev Med Suisse Romande 2000; 120: 703-7.
[13]
Chen LC, Chen YF, Yang LL, Chou MH, Lin MF. Drug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan - a pharmaco-epidemiologic study. J Clin Pharm Ther 2001; 25: 125-9.
[14]
Lammers MW, Hekster YA, Keyser A, Meinardi H, Renier WO, van Lier H. Monotherapy or polytherapy for epilepsy revisited: A quantative assessment. Epilepsia 1995; 36: 440-6.
[15]
Ramya A, Sravya P, Kumar V, Reddy T, Lakhshmi C. Pediatric Seizures – a prospective study on drug utilization pattern and its outcome in a teritiary Care Hospital. World J Pharmaceutical Res 2015; 4: 1561-72.
[16]
Anderson M, Egunsola O, Cherrill J, Millward C, Fakis A, Choonara I. A prospective study of adverse drug reactions to antiepileptic drugs in children. BMJ Open 2015; 5(6): e008298.
[17]
Kousalya K, Swathi Cherukuri DP, Padmasani LN, Arun Prasath TS. Drug utilization pattern of antiepileptics and their adverse effects in pediatrics. World J Pharmaceutical Res 2014; 3(9): 504-13.
[18]
Mathur S, Sen S, Ramesh L, Kumar S. Utilization pattern of antiepileptic drugs and their adverse effects in a teaching hospital. Asian J Pharm Clin Res 2010; 3: 55-60.
[19]
George J, Chanda K, Sharma GRK. Antiepileptic drugs and quality of life in patients with epilepsy: A Tertiary Care Hospital-based study. Value Health Reg Issues 2015; 6: 1-6.
[20]
Mistry RA, Solanki KC, Prajapati HK, Doshi TM, Trivedi HR. Drug utilization pattern of antiseizure drugs and their adverse effects in the pediatric population, in a tertiary care hospital attached to a medical college. Int J Basic Clin Pharmacol 2014; 3: 336-42.
[21]
Karimzadeh P, Bakrani V. Antiepileptic Drug-Related Adverse Reactions and factors influencing these reactions. Iran J Child Neurol 2013; 7: 25-9.
[22]
Gosavi DD, Suman A, Jain M. Sodium valproate induced increased frequency of micturition and enuresis. Ind J Pharmacol 2013; 45: 87-8.
[23]
23 Cheng W, Lin X, Lu D. Sodium valproate-induced enuresis in a pediatric bipolar patient. Neuropsychiatr Dis Treat 2013; 9: 1671-2.
[24]
Junger KW, Morit D, Modi AC. The pediatric epilepsy side effects questionnaire: Establishing clinically meaningful change. Epilepsy Behav 2015; 45: 101-4.